Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/11/13 12:49 Updated
Market Cap: $886.5M (¥141.6B)
Stock Price: $11.94 (¥1,907)
Exchange Rate: 1 USD = ¥159.74

Consolidated Financial Summary for the Second Quarter of Fiscal Year Ending March 2027

Revenue of 65,131 million yen (Year-over-Year +5.9%), operating profit of 6,168 million yen (+19.3%), and EBITDA of 11,473 million yen (+14.7%). Full-year forecast remains unchanged for now and progress is broadly in line with expectations. Key contributing segments include Vision Care, 1DAY, and Ortho-K.

Importance:
Page Updated: November 13, 2026
IR Disclosure Date: November 13, 2026

Key Figures

  • Revenue: 65,131 million yen
  • Operating Profit: 6,168 million yen
  • EBITDA: 11,473 million yen

AI要約

Business Performance Overview

For the second quarter of the fiscal year ending March 2027, consolidated revenue was 65,131 million yen, a Year-over-Year increase of 5.9%. The main drivers were expansion of 1DAY membership and increased overseas sales. In addition, selling, general and administrative expenses were contained through cost-structure reviews, resulting in operating profit expanding to 6,168 million yen (+19.3%). EBITDA was 11,473 million yen (+14.7%), and EBITDA margin improved by 1.3 percentage points year-over-year. Net income at the end was 3,578 million yen, exceeding the same period last year.

Outlook and Key Uncertainties

The full-year forecast has not been substantially revised based on current progress, and foreign exchange assumptions at the reporting time are applied. Market factors that may affect results include the weak yen, regional economic conditions, sustainability of 1DAY membership growth, and region-specific demand for Ortho-K related products. Attention should also be paid to cost impacts associated with ongoing investments such as capital expenditures at the Malaysia plant.

Revenue Trend

Operating Profit Trend

EBITDA Trend

Gross Profit Margin, SG&A Ratio, Operating Margin

Comparison of Full-Year Guidance and Results

Item Actual Forecast Progress
Revenue 133,000 133,000 49
This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →